Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026)

Exelixis (EXEL) posted quarterly Change in Acquisitions & Divestments of $225.1 million for Q2 2026, down 13.05% year-over-year from $258.9 million in Q2 2025, and up 18.9% quarter-over-quarter from $189.3 million in Q1 2026.

Analysis

Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Exelixis' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $225.1 million for Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments fell 13.05% year-over-year to $225.1 million; the TTM figure through Apr 2026 stood at $989.1 million (up 13.98% YoY), while the FY2026 annual figure was $1.0 billion, up 16.59% from the prior year.
  • Change in Acquisitions & Divestments for Q2 2026 stood at $225.1 million, up from $189.3 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $353.1 million in Q3 2025, with the low at $153.5 million in Q4 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $238.0 million (2022), against an average of $248.7 million.
  • The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments sank 46.18% in 2024, then soared 64.02% in 2025.
  • Exelixis' Change in Acquisitions & Divestments stood at $238.0 million in 2022, then sank by 35.5% to $153.5 million in 2023, then increased by 9.07% to $167.4 million in 2024, then jumped by 32.31% to $221.5 million in 2025, then grew by 1.63% to $225.1 million in 2026.
  • Business Quant data shows EXEL's Change in Acquisitions & Divestments at $225.1 million in Q2 2026, $189.3 million in Q1 2026, and $221.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 169.27 Mn
Apr 3, 2026 225.13 Mn
Jan 2, 2026 189.34 Mn
Oct 3, 2025 221.51 Mn
Jul 4, 2025 353.10 Mn
Apr 4, 2025 258.92 Mn
Jan 3, 2025 226.16 Mn
Sep 27, 2024 167.42 Mn
Jun 28, 2024 215.28 Mn
Mar 29, 2024 268.45 Mn
Dec 29, 2023 153.49 Mn
Sep 29, 2023 311.08 Mn
Jun 30, 2023 263.14 Mn
Mar 31, 2023 310.77 Mn
Dec 30, 2022 237.99 Mn
Sep 30, 2022 326.41 Mn
Jul 1, 2022 232.74 Mn
Apr 1, 2022 267.62 Mn
Dec 31, 2021 282.70 Mn
Oct 1, 2021 381.73 Mn